publication date: Feb. 7, 2020

American Cancer Society CEO Gary Reedy cedes day-to-day operations to chief operating officer

By Paul Goldberg

In what appears to be a significant reorganization, Gary Reedy, CEO of the American Cancer Society, announced to the staff of the Atlanta-based charity that he will be stepping away from its day-to-day operations.

“I recognize the need for me to focus my efforts externally, which requires different leadership to oversee day-to-day operations,” Reedy said in an email dated Feb. 5 and addressed to the ACS staff. “To that end, we are embarking on the process of recruiting a Chief Operating Officer (COO).”

A copy of the email was obtained by The Cancer Letter.

Characterizing the changes as “exciting news,” Reedy wrote that the “changes to the senior staff… will better position the American Cancer Society to deliver on the three-year enterprise strategic plan so that we may meet the challenge goal to reduce cancer mortality by 40 percent by 2035.”

Leaving the ACS day-to-day operations to a chief operating officer represents a change in strategy for Reedy, who during his nearly five years on the job sought to flatten the ACS organizational structure.

The society hasn’t had a COO since Gregory Bontrager departed from that post in late 2014. Reedy, formerly a Johnson & Johnson executive, accepted the CEO job in April 2015. Now, “the Board and I have asked Kris Kim, executive vice president for the Northeast Region, to step in as Acting Chief Operating Officer,” Reedy wrote in the email to the staff.

Responding to questions from The Cancer Letter, Reedy described the decision to bring in the COO as a logical next step in his turnaround plan for ACS.

Continue reading American Cancer Society CEO Gary Reedy cedes day-to-day operations to chief operating officer
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.